Effectiveness and safety of Autologous Virus-Specific T Cell Therapy for Persistent COVID-19 in People with Immunocompromise: A Clinical Trial Study

Journal:
Clinical Infectious Diseases
Published:
DOI:
10.1093/cid/ciaf302
Affiliations:
6
Authors:
12
Go to article
Institutions Authors Share
The Catholic University of Korea (CUK), South Korea
7.666667
 0.64
LucasBio, South Korea
4.333333
 0.36
Interested in Immunology?